期刊文献+

对氧磷酶-1与2型糖尿病的关系研究

Study on the relationship between paraoxonase-1 and type 2 diabetes mellitus
下载PDF
导出
摘要 目的:探讨对氧磷酶-1(PON-1)与2型糖尿病(T2DM)的关系。方法:测定63例T2DM患者和33例健康人血清PON-1活性,并应用聚合酶链式反应—限制性片段长度多态性(PCR-RFLP)技术研究其PON-1第191位密码子基因变异。结果:(1)T2DM组血清PON-1活性低于对照组,差别具有统计学意义(t=2.75,P<0.05)。(2)T2DM组与对照组PON-1第191位密码子基因型分布无显著性差异(2χ=3.03,P>0.05)。结论:T2DM组血清PON-1活性显著低于对照组,这可能是T2DM患者血管疾病高发的原因之一。 Objective: To reveal the relationship between serum paraoxonase-1 (PON-1) activity, PON-1 Q/R polymorphism and type 2 diabetes mellitus in Chinese Han ethnic group. Methods: The subjects of the study consisted of two groups: (1) type 2 diabetes mellitus group; (2) normal-control group. Serum PON-1 activity was determined using paraoxon as substrate by measuring the increase rate in the absorbance at 405 nm due to formation of 4-nitrophenol, and PON-1 Q/R polymorphism was evaluated by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Results:(1) There was no significant difference in the distribution of the PON-1 Q/R polymorphism between T2DM group and normal-control group (X^2 =3.03,P〉0.05). (2) Serum PON-1 activity in T2DM group and normal-control group was (44.65±19.96)u/ml and (74.85±27.72)u/ml, respectively. Serum PON-1 activity in the former group was significantly low compared with the control group (t=2.75,P 〈0.05). Conclusion: The present study suggests that serum PON-1 activity in T2DM group is significantly lower than the control group. Perhaps it is one of the reasons why T2DM patients are highly complicated with vascular diseases.
出处 《天津医科大学学报》 2007年第4期514-515,535,共3页 Journal of Tianjin Medical University
关键词 2型糖尿病 对氧磷酶-1 血清对氧磷酶-1活性 基因多态性 Type 2 diabetes mellitus PON-1 Serum PON-1 activity Polymorphism
  • 相关文献

参考文献6

  • 1Wastson AD, Berliner JA, La DU BN, et al. Protective effect of high density lipoprotein associated paraoxonase [J]. J Clin Invest, 1995, 96(6):2 882.
  • 2Mackness MI, Harty D, Bhatnagar D, et al. Serum paraoxonase activity in familiar hypercholesterolaemia and insulin-dependent diabetes mellitus [J]. Athemsclerosis, 1991,86(2/3):193.
  • 3Humbert R, Alder DA, Disteche CM, et al. The molecular basis of the human serum paraoxonase activity polymorphism [J]. Nat Genet, 1993,3(1):73.
  • 4Suehiro T, Nakamura T, Inoue M, et al. A polymorphism upstream from serum the human paraoxonase(PON1) gene and its association with PON1 expression [J]. Atherosclerosis, 2000, 150(2):295.
  • 5Mackness B, Mackness MI, Arrol S, et al. Serum paraoxonasc (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non - insulin dependent diabetes mellitus [J]. Atherosclerosis, 1998, 139(2):341.
  • 6Wijk J, Coll B, Cabezas MC, et al. Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients [J]. Clin Exp Pharmacol Physiol, 2006,33 (12): 1134.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部